MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 157 filers reported holding MERSANA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,426 | -89.9% | 42,068 | -73.8% | 0.00% | -100.0% |
| Q2 2023 | $527,397 | +6013.3% | 160,303 | +7537.1% | 0.00% | – |
| Q1 2023 | $8,627 | +72.5% | 2,099 | +182.9% | 0.00% | – |
| Q3 2022 | $5,000 | -44.4% | 742 | -63.3% | 0.00% | – |
| Q2 2022 | $9,000 | -87.5% | 2,023 | -88.8% | 0.00% | – |
| Q1 2022 | $72,000 | +800.0% | 18,123 | +1269.8% | 0.00% | – |
| Q4 2021 | $8,000 | -77.8% | 1,323 | -65.6% | 0.00% | – |
| Q3 2021 | $36,000 | -75.0% | 3,849 | -56.6% | 0.00% | – |
| Q1 2021 | $144,000 | +34.6% | 8,870 | +121.4% | 0.00% | – |
| Q4 2020 | $107,000 | – | 4,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |